The effects of the different blood lipid components on the T2DM occurrence in metabolic syndrome(MS) versus non-MS patients

( views:127, downloads:0 )
Author:
CHEN Feng-mei()
GUO Zhi-rong()
HU Xiao-shu()
()
()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 19, Issue 08, 2011
DOI:
10.3969/j.issn.1006-6187.2011.08.002
Key Word:

Abstract:

  • [1]Grundy SM,Howard B,Smith S Jr,et al.Prevention Conference VI:Diabetes and Cardiovascular Disease:executive summary:conference proceeding for healthcare professionals from a special writing group of the American Heart Association.Circulation,2002,105:2231-2239.
  • [2]胡晓抒,郭志荣,周慧,等.江苏省35-74岁人群代谢综合征的流行病学调查.中华流行病学杂志,2006,27:571-576.
  • [3]Scott MG,James IC,Stephen RD,et al.Diagnosis and management of the metabolic syndrome.An American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Circulation,2005,112:2735-2752.
  • [4]李延兵,翁建平.保护细胞功能以改善2型糖尿病的自然病程.国外医学内分泌学分册,2005,25:181.
  • [5]National Cholesterol Education Program Expert Panel.Executive summary of third repost of the national cholesterol education program(NCEP)expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ).JAMA,2001,285:2486-2497.
  • [6]李健斋.非高密度脂蛋白胆固醇-新提出的降脂治疗第二目标.临床检验杂志,2004,22:1-2.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn